Researchers discover new type of technology to detect ovarian cancer

Published On 2022-09-12 09:21 GMT   |   Update On 2022-12-07 10:42 GMT

A new type of technology can capture stray ovarian cancer cells from a simple blood test and successfully predict cancer in people who have a lesion or cyst in the pelvic region, according to a new study by a Wilmot Cancer Institute physician/scientist.Nearly 200 local people participated in the study, which was led by Richard Moore, M.D., director of the Wilmot Cancer Institute's...

Login or Register to read the full article

A new type of technology can capture stray ovarian cancer cells from a simple blood test and successfully predict cancer in people who have a lesion or cyst in the pelvic region, according to a new study by a Wilmot Cancer Institute physician/scientist.

Nearly 200 local people participated in the study, which was led by Richard Moore, M.D., director of the Wilmot Cancer Institute's Gynecologic Oncology program at the University of Rochester Medical Center. Results were published on Sept. 8, 2022, in the high-impact Obstetrics & Gynecology "Green" journal.

Reference:

Moore, Richard George MD et al, Malignancy Assessment Using Gene Identification in Captured Cells Algorithm for the Prediction of Malignancy in Women With a Pelvic Mass, Obstetrics and Gynecology, Sep 2022 DOI: 10.1097/AOG.0000000000004927

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News